Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT02932917
Other study ID # XAP062
Secondary ID
Status Enrolling by invitation
Phase Phase 1
First received October 12, 2016
Last updated May 19, 2017
Start date June 2016
Est. completion date December 2017

Study information

Verified date May 2017
Source University of St Andrews
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Place-based cues can be an important trigger of smoking behavior, therefore the investigators wish to learn more about the influence of the built environment on individual smoking behavior. This is to facilitate dynamic support during the post-quit phase. MapMySmoke is a mobile phone application that enables the capture of spatial data during smoking and craving events. These data will be used to create individualized support plans via the app.


Description:

Investigators know that place-based cues play an important role in the triggering of smoking events, and even in relapse events. It follows that providing individual smokers with spatially explicit and temporally dynamic intervention messages may support smoking cessation attempts.

The investigators have built a mobile phone application—MayMySmoke—that allows individuals to capture each smoking event at the times and places they occur, and tag the events with qualitative metadata. The app also allows individuals to document and describe craving events. The goal of the app is first to understand an individual's smoking profile, and second to support them with dynamic text messages.

The investigators are deploying the app in a clinical setting—the United Kingdom's National Health Service, within the Fife region of Scotland. Using two feasibility studies of increasing size, the investigators are attempting first to get initial feedback on the app, and then to improve the app and deploy it across a broader community of smokers.

Though the app is targeted to smoking behavior, it is possible to extend it to include other negative health behaviors that may have a spatial component.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 110
Est. completion date December 2017
Est. primary completion date December 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- National Health Service (Fife) Patients

- Self-reported tobacco smoker

- Stated intention to quit smoking

- English speaker

Exclusion Criteria:

- Mental illness

- learning difficulty

Study Design


Related Conditions & MeSH terms


Intervention

Device:
MapMySmoke
Each patient in the study arm will download and install the MapMySmoke app to record all of their smoking and craving events. The app will generate a quantitative summary of their smoking behavior during a pre-quit phase, and will provide dynamic text support messages during the post-quit phase. The app will also capture spatial details of any relapse events during the post-quit phase.

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
University of St Andrews National Health Service, United Kingdom

Outcome

Type Measure Description Time frame Safety issue
Primary Continued use of the MapMySmoke App as Assessed by Monitoring Individual Anonymized Data Feeds on the Server The investigators will determine, via the data feed to the server, if patients continue to use the app during the pre- and post-quit phase 1 year
Secondary Number of Patients Using the App Who Are Abstinent from Smoking As Assessed by Follow-up Survey The investigators will determine via survey if patients have maintained their quit attempt 4 weeks
Secondary Number of Patients Using the App Who Are Abstinent from Smoking As Assessed by Follow-up Survey The investigators will determine via survey if patients have maintained their quit attempt 3 months
See also
  Status Clinical Trial Phase
Completed NCT03999411 - Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients Phase 4
Completed NCT03931772 - Online Automated Self-Hypnosis Program N/A
Completed NCT02649556 - A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2 N/A
Completed NCT03901066 - Smoking Dependence and Periodontitis
Recruiting NCT05846841 - Personalized Tobacco Treatment in Primary Care (MOTIVATE) N/A
Completed NCT03170752 - Implementing and Testing a Cardiovascular Assessment Screening Program (CASP) N/A
Completed NCT03305978 - Pulmonary Nodule Detection: Comparison of an Ultra Low Dose vs Standard Scan. N/A
Completed NCT00000437 - Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone) Phase 4
Completed NCT06105424 - BRP1602: Evaluation of Technical and Logistical Feasibility to Measure Lung Permeability N/A
Active, not recruiting NCT02752022 - Monitoring the Transition From Smoking to E-cigarettes
Completed NCT02912000 - TEACH: Technology Evaluation to Address Child Health N/A
Completed NCT04340830 - The Effect of Smoking on Dimensional Changes of Free Gingival Graft Around Dental Implants N/A
Completed NCT03206619 - A Health Recommeder System to Tailor Message Preferences in a Smoking Cessation Programme
Completed NCT02901171 - The Contribution of a Smartphone Application to Acceptance and Commitment Therapy Group Treatment for Smoking Cessation N/A
Completed NCT02949648 - Electronic Cigarette Use and Quitting in Youth N/A
Completed NCT02945371 - Tailored Inhibitory Control Training to Reverse EA-linked Deficits in Mid-life N/A
Completed NCT02246114 - Self-Monitoring of Carbon Monoxide to Enhance Reproductive Outcomes in Women N/A
Completed NCT01898507 - Nicotine Metabolism and Low Nicotine Cigarettes N/A
Completed NCT02008292 - Acetylcholine, Tobacco Smoking, Genes and Nicotinic Receptors N/A
Completed NCT01954407 - Young Adults' Responses to Anti-smoking Messages N/A